Recent data from landmark trials suggest that the indications for cardiac pacing and implantable cardioverter defibrillators (ICDs) are set to expand to include heart failure, sleep-disordered breathing, and possibly routine implantation in patients with myocardial infarction and poor ventricular function.
INTRODUCTION
Although there are quite a few case reports of patients with automatic implantable cardioverter defibrillators (AICDs) undergoing noncardiac surgeries, there is hardly any case report for cardiac surgery.
With the increasing number of patients being implanted with these devices, we are more likely to face the unique challenges posed by these patients undergoing cardiac surgeries and hence the relevance of this case report.
CASE REPORT
A 6 3 -y e a r-o l d f e m a l e , n o n d i a b e t i c , nonhypertensive patient presented with a history of generalized weakness, atypical chest pain, dyspnea on exertion for 8 months, which had worsened for 2 months. There was a history of paroxysmal nocturnal dyspnea for 15 days. She had no other comorbidities.
Transesophageal Echocardiography with Doppler revealed severe mitral regurgitation, moderate aortic stenosis, severe TR, and severe pulmonary arterial hypertension. Global left ventricular (LV) hypokinesia with ejection fraction of 35%.
Blood pressure was maintained with high inotropic support [ Figure 3 ].
In addition to the regular anesthetic management, the perioperative period involved reprogramming of the device at various stages of the surgery as follows: She was scheduled to undergo double valve replacement with or without tricuspid repair. The night before the scheduled surgery, the patient developed severe acute pulmonary edema as evident in the chest X-ray [ Figure 2 ]. She had to be intubated and put on ventilator support. The pacing rate was increased to 90 beats/min.
M o n i t o r i n g i n c l u d e d Tr a n s e s o p h a g e a l echocardiography (ECG), pulse oximetry, EtCO2, central venous pressure, invasive blood pressure, temperature, and urine output.
Swan-Ganz is not used routinely in our set up as we have TEE for assessment. Moreover, in this patient, the presence of thick AICD coil in the RV and the presence of tricuspid regurgitation (TR) would have made folating the Swan-Ganz difficult. • To avoid electromagnetic interference from the electrocautery, the VT/VF therapy was switched off, which would otherwise result in unnecessary shocks being delivered to the patient. External paddles had been attached to the patient in case shock needs to be delivered before sternum is opened. VVI pacing was kept on [ Figure 6 ] • After heparinization and cannulation, the patient was put on cardiopulmonary bypass support. The pacing was now stopped (changed to monitoringonly mode (OVO) mode) [ Figure 7 ] to facilitate cardiac arrest by cardioplegia • After replacement of the valves and complete rewarming, the pacing was restarted with VVI mode initially at 80 beats/min, increased to 90/min to facilitate separation from bypass [ Figure 8 ]. The anti-VT/VF therapy was still kept off • After completion of hemostasis and chest closure, the AICD was reprogrammed to switch on the VT/VF therapy. Postoperative TEE assessment showed well-functioning bioprosthetic mitral and aortic valves with no paravalvular leak. Mean gradient across the prosthetic mitral valve was 4 mmHg and across the aortic was 7 mmHg. Postoperatively, LV dysfunction persisted with an LV internal diameter (diastole) of 6 cm.
The patient had an uneventful postoperative course and recovery and was discharged with advice for reinterrogation of the device function a week later.
CONCLUSIONS
While magnet application to control the electronic device functions is appropriate in some cases, in others magnet application alone might fail to address all the necessary perioperative issues.
[3] 
